readthroughSign in
CompanyMGNXNasdaqRockville, MD

MacroGenics

MacroGenics develops monoclonal antibody-based therapeutics for cancer treatment using proprietary next-generation antibody technology platforms and protein engineering expertise.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 12Latest story